PROTAGONIST THERAPEUTICS INC (PTGX)

US74366E1029 - Common Stock

39.57  +0.59 (+1.51%)

After market: 39.57 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
323.80M60.00M26.58M27.36M28.63M
Operating Expenses
174.68M153.65M157.95M153.20M93.14M
Research and Development
132.12M120.16M126.22M126.01M74.51M
Selling, General, and Administrative Expenses
42.56M33.49M31.74M27.20M18.64M
Operating Income
149.11M-93.65M-131.37M-125.85M-64.51M
Interest Income/Expense
23.70M14.90M4.06M440.00K300.00K
Other Income/Expense
263.00K-201.00K-80.00K-150.00K-50.00K
Non Recurring Items
N/AN/A0.000.00-590.00K
Income Before Taxes
173.08M-78.95M-127.39M-125.55M-64.85M
Income Tax
N/AN/A0.000.001.31M
Net Income
170.85M-78.95M-127.39M-125.55M-66.15M
EBITDA
150.07M-92.67M-130.34M-125.04M-63.72M
 
Per Share Data
EPS Diluted Total Ops
2.68-1.39-2.60-2.71-1.92
Non GAAP EPS
2.66-1.49-2.60-2.70-2.02
 
Statistics
Profit Margin
52.76%-131.59%-479.27%-458.88%-231.05%
Operating Profit Margin
46.05%-156.09%-494.24%-459.98%-225.32%

All data in USD

Charts